USP13 and cervical cancer: Mcl-1 is a pro-survival protein that is often associated with resistance to BH3 mimetic treatment [97]; this study demonstrated that the depletion or inhibition of USP13 sensitises HPV+ cervical cancer cells to BH3-mimetics, a potential therapeutic approach in these cancers [98].